Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03349528 · ClinicalTrials.gov registry record · Phase 2
Probiotics to Prevent Relapse After Hospitalization for Bipolar Depression
A Phase 2 study, sponsored by Sheppard Pratt Health System.
- Active
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
NCT03349528: Active Phase 2 study, sponsored by Sheppard Pratt Health System.
NCT03349528 is a Phase 2 study that is active but no longer recruiting, run by Sheppard Pratt Health System. The registered enrollment target is 80 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (40% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03349528, a Phase 2 study, is active but no longer recruiting, sponsored by Sheppard Pratt Health System.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if taking a probiotic supplement versus a placebo will reduce relapse and improve the clinical course among participants who have been hospitalized for bipolar depression.
Primary Outcome
Time to relapse defined as time until psychiatric rehospitalization during the study period
Interventions
- BIOLOGICAL Inert Compound
- BIOLOGICAL Probiotic Supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2018-12-11 |
| Est. Completion | 2027-12 |
| Phase | Phase 2 |
What the registry record for NCT03349528 still lists
NCT03349528 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (40% lower).
The record links to 0 conditions, and to 2 interventions - of which Inert Compound is the first listed.
NCT03349528 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03349528 about?
NCT03349528 is a clinical study titled "Probiotics to Prevent Relapse After Hospitalization for Bipolar Depression". The purpose of this study is to determine if taking a probiotic supplement versus a placebo will reduce relapse and improve the clinical course among participants who have been hospitalized for bipolar depression.
What is the current status of trial NCT03349528?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2018-12-11. Estimated completion is 2027-12.
What interventions are being tested in trial NCT03349528?
The interventions under investigation include: Inert Compound (BIOLOGICAL), Probiotic Supplement (BIOLOGICAL).
Who is sponsoring clinical trial NCT03349528?
This trial is sponsored by Sheppard Pratt Health System, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03349528's enrollment target sits among peer trials
80 842nd of 2000 higher than 1,117 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI